Detalles de la búsqueda
1.
LEAP2 is associated with cardiometabolic markers but is unchanged by antidiabetic treatment in people with prediabetes.
Am J Physiol Endocrinol Metab
; 325(3): E244-E251, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37436962
2.
Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial).
BMJ Open
; 7(5): e013802, 2017 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28592573
Resultados
1 -
2
de 2
1
Próxima >
>>